Locations:
Search IconSearch

Don’t Miss These Cole Eye Institute Experts at AAO 2019

Speakers and topics for Booth 7125

19-EYE-4239-AAO-CQD

If you’re planning to attend the American Academy of Ophthalmology’s annual meeting in San Francisco Oct. 12-15, you’ll want to visit Cleveland Clinic Cole Eye Institute’s booth (No. 7125) to hear timely research and clinical presentations, ask follow-up questions and discuss your difficult cases with our nationally and internationally renowned experts.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Here’s the speaker schedule:

Saturday, Oct. 12

12 p.m. Craig See, MDManagement of Endothelial Keratoplasty Complications

2 p.m. Katherine Talcott, MDSurgical Innovations and Complications

Sunday, Oct. 13

12 p.m. Aleksandra Rachitskaya, MDNovel Imaging and Surgical Visualization Techniques

2 p.m. Arun D. Singh, MDIntraocular Tumors: What is New?

Monday, Oct. 14

10 a.m. William J. Dupps, MD, PhD, J. Bradley Randleman, MD, and Steven E. Wilson, MD,Updates in Refractive Surgery and Cross-Linking

12 p.m. Julian D. Perry, MD and Catherine Hwang, MDHow to Look Your Best

2 p.m. Daniel Petkovsek, MD – Cole Eye Residency Program

Follow us on Twitter during AAO 2019 @CleClinicMD.

Advertisement

Related Articles

OCT scan showing dry AMD
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data shows risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

23-EYE-4196362-inflammation-retinal-regeneration-CQD-Hero
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

23-EYE-4051658-CQD-ChatGPT-in-Ophthalmology-Research
Don’t Believe Everything Chatbots Say About Ophthalmic Research

30% of references generated by ChatGPT don’t exist, according to one study

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero
Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD
DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

22-EYE-3049477 New findings in retinal regeneration-Perkins-650×450-4
Restoring the Retina: How to Regenerate Photoreceptors in Inherited Retinal Dystrophy

Notch pathway inhibition preserves retinal neurons and promotes regrowth in zebrafish

Ad